Pitavastatin is a statin-class medication that acts as an HMG-CoA reductase inhibitor to manage hypercholesterolemia and reduce cardiovascular risk by lowering LDL cholesterol and triglycerides. In the… Read more





























Pitavastatin is a statin-class medication that acts as an HMG-CoA reductase inhibitor to manage hypercholesterolemia and reduce cardiovascular risk by lowering LDL cholesterol and triglycerides. In the pharmaceutical industry, reference standards for Pitavastatin and its related compounds are essential tools for maintaining quality control and regulatory compliance. Laboratories use these high-quality reference materials—including process-related impurities, synthetic intermediates, degradation products, and stable isotope labelled compounds—to support critical analytical tasks. These include impurity profiling, structural characterization, and method validation during development and batch release testing. By providing a precise benchmark for identifying and quantifying substances, these standards ensure the safety, efficacy, and purity of the final drug product in accordance with international guidelines. The availability of diverse labelled standards further enables accurate quantification in complex bioanalytical studies, ensuring the integrity and reliability of pharmaceutical testing processes.